GO:0035091 phosphatidylinositol binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035091 phosphatidylinositol binding is a molecular function describing the binding of a protein or small molecule to phosphatidylinositol (PtdIns) and its phosphorylated derivatives, collectively called phosphoinositides.
• Phosphoinositide-binding proteins, including Phafins and PITPs, decode membrane lipid signals and control membrane trafficking, autophagy, and immune signaling.
• Phosphatidylinositol flippases regulate phosphoinositide homeostasis at the plasma membrane, showing that lipid distribution itself is an actively controlled process.
• STING activation is regulated by phosphoinositide and cholesterol, directly linking phosphatidylinositol binding to innate immunity.
• Small molecules such as neomycin bind PIP2 and bacterial phosphatidylinositol-specific phospholipase C binds interfacial phosphatidylinositol, illustrating the chemical diversity of this binding function.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to test whether candidate phosphatidylinositol-binding proteins are causally involved in a phenotype.
Description
Phosphatidylinositol binding (GO:0035091) is a molecular function that describes the selective interaction of a protein or chemical entity with phosphatidylinositol (PtdIns) and its phosphorylated derivatives. Phosphatidylinositol is an inositol-containing glycerophospholipid that can be phosphorylated at multiple positions to generate phosphoinositides such as PI(4)P, PI(4,5)P2, and PI(3,4,5)P3, which act as membrane-embedded signals. Because these lipids are concentrated in specific membrane compartments, proteins that bind them can be targeted to the plasma membrane, endosomes, autophagosomes, or the Golgi, and can change conformation or activity upon binding.
phosphatidylinositol binding At A Glance
| GO ID | GO:0035091 |
|---|---|
| GO term | phosphatidylinositol binding |
| Ontology | molecular_function |
| Synonym | phosphoinositide binding |
| Definition | Binding to an inositol-containing glycerophospholipid, i.e. phosphatidylinositol (PtdIns) and its phosphorylated derivatives. |
| Major function | Recruitment and regulation of proteins at specific membranes through recognition of PtdIns and phosphoinositides. |
| Representative protein families | Phafins, phosphatidylinositol transfer proteins (PITPs), and other phosphoinositide-binding proteins. |
| Related processes | Membrane trafficking, autophagy, innate immune signaling, and phosphoinositide homeostasis. |
| Example small-molecule ligand | Neomycin binds phosphatidylinositol 4,5-bisphosphate (PIP2). |
What Is GO:0035091?
GO:0035091 phosphatidylinositol binding is defined as binding to an inositol-containing glycerophospholipid, i.e. phosphatidylinositol (PtdIns) and its phosphorylated derivatives. The synonym phosphoinositide binding is often used because the phosphorylated forms of PtdIns are collectively called phosphoinositides. This function is a molecular_function in the Gene Ontology and is distinct from enzymatic activities that modify phosphatidylinositol; it describes the binding event itself.
Why Is phosphatidylinositol binding Important in Cell Biology?
Phosphatidylinositol binding is important because it converts the lipid composition of a membrane into a readable signal that controls where proteins assemble and when they are active. This function underlies fundamental processes such as autophagy, where phosphoinositide-binding proteins help build and mature autophagosomes, and innate immunity, where phosphoinositide and cholesterol regulate STING activation. Because phosphatidylinositol derivatives are also targets of bacterial toxins and small molecules, this binding function is relevant to infection, pharmacology, and membrane biology.
• It provides a general mechanism for targeting proteins to specific membranes based on lipid identity.
• It is central to phosphoinositide homeostasis at the plasma membrane through flippases.
• It contributes to autophagy by recruiting phosphoinositide-binding proteins to autophagic membranes.
• It regulates innate immune signaling through STING and its lipid environment.
• It is exploited by bacterial phosphatidylinositol-specific phospholipase C at membrane interfaces.
• It is targeted by small molecules such as neomycin that bind PIP2.
• It is relevant to membrane trafficking and organelle identity through PITP proteins.
• It is a recurring feature of Phafin proteins, which are more than simple phosphoinositide binders.
• It can be studied with lipid-binding assays, imaging, and CRISPR-based perturbation.
• It links lipid biochemistry to cell signaling, immunity, and disease-relevant pathways.
Molecular Mechanism of phosphatidylinositol binding
Membrane recognition and lipid headgroup engagement
In simple terms: The protein first finds the right membrane and touches the inositol headgroup of phosphatidylinositol.
Phosphatidylinositol binding begins with recognition of the inositol-containing headgroup of PtdIns or its phosphorylated derivatives at a membrane surface. Because different phosphoinositides have different phosphorylation patterns, the binding site of a given protein can discriminate among them, allowing selective recruitment to specific compartments. Phosphatidylinositol transfer proteins such as PITP alpha and PITP beta illustrate how ligand and membrane binding behavior can be coupled to lipid transfer and membrane interactions.
Interfacial binding and conformational coupling
In simple terms: Binding happens at the water-lipid boundary and can change the shape or activity of the protein.
Many phosphatidylinositol-binding events occur at the membrane interface, where the protein contacts both the lipid headgroup and the hydrophobic membrane environment. Bacterial phosphatidylinositol-specific phospholipase C has been used to investigate interfacial binding to phosphatidylinositol, showing that surface engagement is a distinct step from catalysis. In eukaryotic cells, phosphoinositide-binding proteins such as Phafins use these interactions to localize and to coordinate downstream functions.
Phosphoinositide homeostasis and flippase activity
In simple terms: Cells actively move phosphatidylinositol between membrane leaflets to keep the right lipids in the right place.
Novel phosphatidylinositol flippases contribute to phosphoinositide homeostasis in the plasma membrane, indicating that the distribution of phosphatidylinositol across the bilayer is actively maintained. This homeostasis influences which proteins can bind phosphatidylinositol at the plasma membrane and therefore affects signaling output. The existence of dedicated flippases shows that phosphatidylinositol binding is not only a protein property but also depends on regulated lipid accessibility.
Regulation by phosphoinositide and cholesterol in immune signaling
In simple terms: Lipids around a signaling protein can switch its activity on or off.
Regulation of STING activation by phosphoinositide and cholesterol demonstrates that phosphatidylinositol-related lipids can directly modulate an innate immune signaling pathway. This places phosphatidylinositol binding within a broader lipid-control network in which membrane composition determines signaling outcomes. The same principle applies to autophagy, where phosphoinositide-binding proteins are required for autophagic membrane events.
Small-molecule and toxin interactions with phosphatidylinositol
In simple terms: Some drugs and bacterial proteins also bind phosphatidylinositol derivatives.
Neomycin binds phosphatidylinositol 4,5-bisphosphate (PIP2), showing that small molecules can compete with or mimic protein-phosphoinositide interactions. Bacterial phosphatidylinositol-specific phospholipase C binds phosphatidylinositol at the membrane interface, illustrating how pathogens target this lipid. These examples broaden the concept of phosphatidylinositol binding beyond canonical eukaryotic protein domains.
Key Genes Involved in GO:0035091 phosphatidylinositol binding
The following genes and proteins represent major experimental entry points for studying phosphatidylinositol binding (GO:0035091).
| Gene | Major Role | Research Relevance |
|---|---|---|
| PITPNA | Phosphatidylinositol transfer protein alpha; binds and transfers PtdIns | Ligand and membrane-binding behavior of PITP alpha can be studied biochemically |
| PITPNB | Phosphatidylinositol transfer protein beta; binds and transfers PtdIns | Comparison of PITP beta membrane binding informs lipid transfer mechanisms |
| STING1 | Innate immune adaptor regulated by phosphoinositide and cholesterol | Links phosphatidylinositol-related lipids to immune signaling |
| PLEKHA1 | Pleckstrin homology domain-containing protein implicated in phosphoinositide binding | Useful for studying phosphoinositide-binding protein families |
| PLEKHA2 | Pleckstrin homology domain-containing protein implicated in phosphoinositide binding | Model for Phafin-related phosphoinositide recognition |
| PLEKHA3 | Pleckstrin homology domain-containing protein implicated in phosphoinositide binding | Candidate for membrane recruitment studies |
| PLEKHA4 | Pleckstrin homology domain-containing protein implicated in phosphoinositide binding | Candidate for phosphoinositide-binding assays |
| PLEKHA5 | Pleckstrin homology domain-containing protein implicated in phosphoinositide binding | Candidate for phosphoinositide-binding assays |
| PLEKHA6 | Pleckstrin homology domain-containing protein implicated in phosphoinositide binding | Candidate for phosphoinositide-binding assays |
| PLEKHA7 | Pleckstrin homology domain-containing protein implicated in phosphoinositide binding | Candidate for phosphoinositide-binding assays |
| PLEKHA8 | Pleckstrin homology domain-containing protein implicated in phosphoinositide binding | Candidate for phosphoinositide-binding assays |
| ATG14 | Autophagy-related protein involved in phosphoinositide-dependent autophagosome formation | Used to study phosphoinositide-binding proteins in autophagy |
| WIPI1 | Phosphoinositide-binding protein in autophagy | Model for autophagic phosphoinositide recognition |
| WIPI2 | Phosphoinositide-binding protein in autophagy | Model for autophagic phosphoinositide recognition |
| MAP1LC3B | Autophagy marker associated with phosphoinositide-rich membranes | Readout for autophagy-related phosphatidylinositol binding |
| PLC | Bacterial phosphatidylinositol-specific phospholipase C | Tool for interfacial binding studies on phosphatidylinositol |
| PIP5K1A | Phosphatidylinositol 4-phosphate 5-kinase; generates PIP2 | Indirectly controls availability of phosphoinositide ligands |
| FIG4 | Phosphoinositide phosphatase involved in phosphoinositide homeostasis | Relevant to phosphatidylinositol derivative turnover |
How Is phosphatidylinositol binding Regulated?
Phosphatidylinositol binding is regulated at multiple levels. First, the abundance and phosphorylation state of phosphatidylinositol derivatives determine which ligands are available; phosphatidylinositol flippases contribute to phosphoinositide homeostasis in the plasma membrane. Second, membrane lipid composition, including cholesterol, can modulate the activity of phosphoinositide-sensitive proteins such as STING. Third, phosphoinositide-binding proteins themselves can be regulated by conformational changes and by interaction with other proteins, as seen in the Phafin family. Finally, in autophagy, the recruitment of phosphoinositide-binding proteins is tightly coordinated with autophagosome formation.
phosphatidylinositol binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STING1 | Innate immune signaling and inflammation | Knockout and point-mutation models to test lipid-binding residues |
| ATG14 | Autophagy and neurodegeneration | Knockout and rescue with phosphoinositide-binding mutants |
| WIPI2 | Autophagy and membrane trafficking | Knockout and tagged knock-in for localization studies |
| PITPNA | Lipid transfer and membrane homeostasis | Overexpression and point-mutation models |
| FIG4 | Phosphoinositide homeostasis | Knockout and knock-in models for lipid turnover |
Phosphatidylinositol binding in innate immunity and inflammation
STING activation is regulated by phosphoinositide and cholesterol, linking phosphatidylinositol-related lipid binding to innate immune signaling. Dysregulation of this pathway can contribute to inflammatory and autoimmune conditions, making phosphoinositide-binding proteins potential therapeutic targets. Experimental models that alter lipid binding can help define which interactions are required for STING function.
Phosphatidylinositol binding in autophagy and neurodegeneration
Phosphoinositide-binding proteins are central to autophagy, a process that clears damaged proteins and organelles and is implicated in neurodegeneration. Disruption of phosphoinositide recognition can impair autophagosome formation and maturation, potentially contributing to neuronal stress. Studying phosphatidylinositol binding in autophagy therefore has direct relevance to neurodegenerative disease models.
Phosphatidylinositol binding and membrane homeostasis disorders
Phosphatidylinositol flippases contribute to phosphoinositide homeostasis in the plasma membrane, and defects in lipid distribution can affect membrane function. Because phosphatidylinositol derivatives control trafficking and signaling, altered homeostasis may contribute to metabolic and membrane-related disorders. Model systems that manipulate flippase activity can test these hypotheses.
Pharmacological and toxicological relevance
Small molecules such as neomycin bind PIP2, and bacterial phosphatidylinositol-specific phospholipase C binds phosphatidylinositol at interfaces, showing that this binding function is druggable and can be targeted by pathogens. Understanding these interactions can inform drug design and anti-infective strategies.
From phosphatidylinositol binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for phosphatidylinositol binding-dependent signaling? | CRISPR knockout cell line |
| Which residue mediates phosphoinositide headgroup recognition? | Point-mutation knock-in of the predicted binding residue |
| Where does the protein bind phosphatidylinositol in live cells? | Tagged knock-in with a fluorescent or affinity tag |
| Does increased protein level alter phosphoinositide homeostasis? | Overexpression cell model |
| Does a lipid-binding mutation affect innate immune activation? | Point-mutation and knockout models in immune cells |
| Can a small molecule compete with phosphatidylinositol binding? | Wild-type and binding-site mutant cells treated with compounds |
How to Study the phosphatidylinositol binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipid overlay assay | Binding to immobilized phosphatidylinositol derivatives | Initial screening of candidate proteins |
| Liposome binding assay | Binding to lipid bilayers of defined composition | Quantitative comparison of wild-type and mutants |
| Fluorescence microscopy | Subcellular localization of tagged proteins | Assigning binding to specific membranes |
| CRISPR knockout | Requirement of a gene for a phenotype | Causal testing of candidate genes |
| Point-mutation knock-in | Role of a specific residue in lipid binding | Mapping binding interfaces in cells |
| Overexpression | Effect of increased protein level | Testing gain of function in lipid homeostasis |
| Biochemical binding assay | Direct protein-lipid interaction | Mechanistic studies with purified proteins |
| Small-molecule competition | Displacement of lipid binding | Pharmacological probing of phosphatidylinositol binding |
Lipid-binding assays
Lipid overlay and liposome-binding assays are used to test whether a protein binds phosphatidylinositol and its phosphorylated derivatives. These methods can compare wild-type and mutant proteins to map the binding interface. They are often the first step in characterizing a candidate phosphatidylinositol-binding protein.
Imaging of phosphoinositide-binding proteins
Fluorescence imaging of tagged proteins, including knock-in fusions, reveals where phosphatidylinositol binding occurs in cells. Co-localization with organelle markers helps assign the binding event to specific membranes. Live-cell imaging can capture dynamic recruitment during signaling or autophagy.
Genetic perturbation with CRISPR
CRISPR knockout, point mutation, knock-in, and overexpression allow causal testing of phosphatidylinositol-binding proteins. Knockout removes the protein, while point mutation can selectively disrupt lipid binding without eliminating the protein. These approaches are essential to distinguish correlation from causation.
Biochemical and structural analysis
Purified proteins and mutant variants can be used in binding and enzymatic assays to quantify phosphatidylinositol interaction. Structural and interfacial studies of bacterial phospholipase C provide a framework for understanding membrane-facing binding sites. Small-molecule binding studies, such as neomycin-PIP2 interaction, complement protein-based assays.
How CRISPR Can Be Used to Study GO:0035091 phosphatidylinositol binding
Knockout
CRISPR knockout of a candidate phosphatidylinositol-binding gene removes the protein and tests whether it is required for a cellular process such as autophagy or immune signaling. Knockout models are useful for establishing necessity but must be interpreted with care because loss of the protein can affect multiple pathways. Rescue experiments with wild-type and binding-deficient versions help confirm specificity.
Point Mutation
Point-mutation knock-in can alter a single residue predicted to contact the phosphatidylinositol headgroup, separating lipid binding from other functions of the protein. This approach is particularly valuable when complete knockout is lethal or when the protein has multiple domains. Comparing wild-type and point-mutant cells reveals the contribution of phosphatidylinositol binding to the phenotype.
Knock-in
Tagged knock-in introduces a fluorescent or affinity tag at the endogenous locus, allowing localization and interaction studies under native expression control. Knock-in of disease-associated variants can model how altered phosphatidylinositol binding contributes to pathology. This strategy avoids artifacts caused by strong overexpression.
Overexpression
Overexpression of a phosphatidylinositol-binding protein can amplify its membrane recruitment and reveal gain-of-function effects on phosphoinositide homeostasis. It is useful for biochemical purification and for testing whether increased lipid binding is sufficient to drive a phenotype. However, overexpression results should be validated with endogenous-level models.
How EDITGENE Supports phosphatidylinositol binding Research
Researchers studying phosphatidylinositol binding-related genes often need to determine whether a candidate gene is causally involved in a phenotype, which requires precise genetic models rather than correlative observations alone. EDITGENE provides the CRISPR tools and cell models needed to move from candidate lists to mechanistic conclusions.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol binding research.
Frequently Asked Questions About phosphatidylinositol binding
What is phosphatidylinositol binding?
Phosphatidylinositol binding (GO:0035091) is the binding to phosphatidylinositol (PtdIns) and its phosphorylated derivatives, also called phosphoinositides.
What genes are involved in phosphatidylinositol binding?
Genes include PITPNA, PITPNB, STING1, PLEKHA family members, and autophagy-related genes such as ATG14 and WIPI2.
What is the GO ID for phosphatidylinositol binding?
The Gene Ontology ID is GO:0035091, with the synonym phosphoinositide binding.
How is phosphatidylinositol binding studied?
It is studied with lipid-binding assays, imaging of tagged proteins, biochemical assays, and CRISPR-based genetic perturbation.
Why is phosphatidylinositol binding important in autophagy?
Phosphoinositide-binding proteins are required for autophagosome formation and maturation, making this function central to autophagy.
Does phosphatidylinositol binding regulate immunity?
Yes, STING activation is regulated by phosphoinositide and cholesterol, linking phosphatidylinositol-related lipids to innate immune signaling.
What proteins bind phosphatidylinositol 4,5-bisphosphate?
Neomycin binds PIP2, and many phosphoinositide-binding proteins recognize PIP2 through dedicated domains.
Can CRISPR be used to study phosphatidylinositol binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression are used to test the causal role of phosphatidylinositol-binding proteins.
What is the difference between phosphatidylinositol binding and phosphoinositide binding?
They are synonyms; phosphoinositide binding emphasizes the phosphorylated derivatives of phosphatidylinositol.
Which experimental model is best for phosphatidylinositol binding research?
The best model depends on the question; knockout tests necessity, point mutation tests specific residues, and knock-in allows native localization studies.
Conclusion
Phosphatidylinositol binding (GO:0035091) is a fundamental molecular function that allows proteins and small molecules to read the phosphoinositide code of cellular membranes. It connects lipid biochemistry to autophagy, innate immunity, membrane trafficking, and pharmacological intervention. Understanding which proteins bind phosphatidylinositol, where, and with what consequence requires precise genetic models and biochemical assays.
References
- 1. Muranaka Y et al.. 2024. Novel phosphatidylinositol flippases contribute to phosphoinositide homeostasis in the plasma membrane.. Biochem J 481(18):1187-1202 PMID: 39258799
- 2. Tang T et al.. 2023. Phafins Are More Than Phosphoinositide-Binding Proteins.. Int J Mol Sci 24(9) PMID: 37175801
- 3. Li J et al.. 2026. Regulation of STING activation by phosphoinositide and cholesterol.. Nature 652(8109):499-507 PMID: 41639452
- 4. Lystad AH et al.. 2016. Phosphoinositide-binding proteins in autophagy.. FEBS Lett 590(15):2454-68 PMID: 27391591
- 6. Baptist M et al.. 2016. Ligand and membrane-binding behavior of the phosphatidylinositol transfer proteins PITPα and PITPβ.. Biochem Cell Biol 94(6):528-533 PMID: 27783542
- 7. Wehbi H et al.. 2003. Investigating the interfacial binding of bacterial phosphatidylinositol-specific phospholipase C.. Biochemistry 42(31):9374-82 PMID: 12899624
- 8. Gabev E et al.. 1989. Binding of neomycin to phosphatidylinositol 4,5-bisphosphate (PIP2).. Biochim Biophys Acta 979(1):105-12 PMID: 2537103
